OBJECTIVE: To evaluate the association between tea consumption and the risk of renal cell carcinoma.
METHODS: We searched PubMed,Web of Science and Scopus between 1970 and November 2012. Two evaluators independently reviewed and selected articles based on predetermined selection criteria.
RESULTS: Twelve epidemiological studies (ten case-control studies and two cohort studies) were included in the final analysis. In a meta-analysis of all included studies, when compared with the lowest level of tea consumption, the overall relative risk (RR) of renal cell carcinoma for the highest level of tea consumption was 1.03 (95% confidence interval [CI] 0.89-1.21). In subgroup meta-analyses by study design, there was no significant association between tea consumption and renal cell carcinoma risk in ten case-control studies using adjusted data (RR=1.08, 95% CI 0.84-1.40). Furthermore, there was no significant association in two cohort studies using adjusted data (RR=0.95, 95% CI 0.81-1.12).
CONCLUSION: Our findings do not support the conclusion that tea consumption is related to decreased risk of renal cell carcinoma. Further prospective cohort studies are required.
Written by:
Hu ZH, Lin YW, Xu X, Chen H, Mao YQ, Wu J, Xu XL, Zhu Y, Li SQ, Zheng XY, Xie LP. Are you the author?
Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Reference: Asian Pac J Cancer Prev. 2013;14(3):1691-5.
PubMed Abstract
PMID: 23679258
UroToday.com Renal Cancer Section
